Abstract
The dic(9;20)(p13.2;q11.2) is reported to be present in ∼2% of childhood B-cell precursor acute lymphoblastic leukemia (BCP ALL). However, it easily escapes detection by G-banding analysis and its true prevalence is hence unknown. We performed interphase fluorescence in situ hybridization analyses—in a three-step manner—using probes for: (i) CDKN2A at 9p21, (ii) 20p and 20q subtelomeres and (iii) cen9 and cen20. Out of 1033 BCP ALLs diagnosed from 2001 to 2006, 533 were analyzed; 16% (84/533) displayed 9p21 deletions, of which 30% (25/84) had dic(9;20). Thus, dic(9;20)-positivity was found in 4.7% (25/533), making it the third most common genetic subgroup after high hyperdiploidy and t(12;21)(p13;q22). The dic(9;20) was associated with a female predominance and an age peak at 3 years; 18/25 (72%) were allocated to non-standard risk treatment at diagnosis. Including cases detected by G-banding alone, 29 dic(9;20)-positive cases were treated according to the NOPHO ALL 2000 protocol. Relapses occurred in 24% (7/29) resulting in a 5-year event-free survival of 0.69, which was significantly worse than for t(12;21) (0.87; P=0.002) and high hyperdiploidy (0.82; P=0.04). We conclude that dic(9;20) is twice as common as previously surmised, with many cases going undetected by G-banding analysis, and that dic(9;20) should be considered a non-standard risk abnormality.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rieder H, Schnittger S, Bodenstein H, Schwonzen M, Wormann B, Berkovic D et al. dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995; 13: 54–61.
Slater R, Smit E, Kroes W, Bellomo MJ, Muhlematter D, Harbott J et al. A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11). Leukemia 1995; 9: 1613–1619.
Heerema NA, Maben KD, Bernstein J, Breitfeld PP, Neiman RS, Vance GH . Dicentric (9;20)(p11;q11) identified by fluorescence in situ hybridization in four pediatric acute lymphoblastic leukemia patients. Cancer Genet Cytogenet 1996; 92: 111–115.
Clark R, Byatt SA, Bennett CF, Brama M, Martineau M, Moorman AV et al. Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia 2000; 14: 241–246.
Forestier E, Gauffin F, Andersen MK, Autio K, Borgstrom G, Golovleva I et al. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer 2008; 47: 149–158.
Pichler H, Moricke A, Mann G, Teigler-Schlegel A, Niggli F, Nebral K et al. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. Br J Haematol 2010; 149: 93–100.
Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol 2010; 11: 429–438.
Heerema NA, Sather HN, Sensel MG, Liu-Mares W, Lange BJ, Bostrom BC et al. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999; 94: 1537–1544.
Mitelman F, Johansson B, Mertens F . Mitelman database of chromosome aberrations and gene fusions in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed May 28, 2010.
Song X, Gong S, Yang J, Wang J . Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients. Ann Hematol 2007; 86: 347–351.
An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV et al. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci USA 2008; 105: 17050–17054.
An Q, Wright SL, Moorman AV, Parker H, Griffiths M, Ross FM et al. Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21. Haematologica 2009; 94: 1164–1169.
Jarosova M, Holzerova M, Mihal V, Lakoma I, Divoky V, Blazek B et al. Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases. Cancer Genet Cytogenet 2003; 145: 161–168.
Rabin KR, Man TK, Yu A, Folsom MR, Zhao YJ, Rao PH et al. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51: 171–177.
Schoumans J, Johansson B, Corcoran M, Kuchinskaya E, Golovleva I, Grander D et al. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol 2006; 135: 492–499.
Strefford JC, Worley H, Barber K, Wright S, Stewart AR, Robinson HM et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 2007; 26: 4306–4318.
Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Soderhall S et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010; 24: 345–354.
Kuchinskaya E, Heyman M, Nordgren A, Söderhäll S, Forestier E, Wehner P et al. Interphase FISH deletion analysis of the 9p21 region and prognosis in childhood ALL: results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol. Br J Haematol (in press).
van der Linden MH, Valsecchi MG, De Lorenzo P, Moricke A, Janka G, Leblanc TM et al. Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. Blood 2009; 114: 3764–3768.
Wetzler M, Dodge RK, Mrozek K, Stewart CC, Carroll AJ, Tantravahi R et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Br J Haematol 2004; 124: 275–288.
Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14: 2267–2275.
Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010; 24: 265–284.
Lönnerholm G, Nordgren A, Frost BM, Jonsson OG, Kanerva J, Nygaard R et al. Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids. Leukemia 2009; 23: 209–212.
Mitchell C, Payne J, Wade R, Vora A, Kinsey S, Richards S et al. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99. Br J Haematol 2009; 146: 424–436.
Acknowledgements
We thank Sigrid Sahlén for excellent technical assistance and all colleagues in the Nordic Society of Paediatric Haematology and Oncology who provided patient samples. This work was supported by grants from the Swedish Childhood Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, Karolinska Institutet, the Mary Béve Foundation for Pediatric Cancer Research and Henning, and Ida Persson Foundation.
Author information
Authors and Affiliations
Consortia
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
VZ performed research, analyzed data and wrote the paper. FG performed research and analyzed data. EK and JS performed research. MH identified specimens, provided clinical data, and analyzed data. GL, EB, GB, IG, BG, HE, LC, MN and LP analyzed data. EF and BJ analyzed data and wrote the paper. AN, principal investigator, designed research, analyzed data and wrote the paper.
Rights and permissions
About this article
Cite this article
Zachariadis, V., Gauffin, F., Kuchinskaya, E. et al. The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial. Leukemia 25, 622–628 (2011). https://doi.org/10.1038/leu.2010.318
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.318
Keywords
This article is cited by
-
Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
Leukemia (2023)
-
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
npj Precision Oncology (2023)
-
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
Leukemia (2019)
-
Significance of Cytogenetics in Leukemia Diagnostics
Current Genetic Medicine Reports (2018)
-
PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia
Molecular Cytogenetics (2015)